2018
DOI: 10.1111/epi.14545
|View full text |Cite
|
Sign up to set email alerts
|

Screening for depression in youth with epilepsy: The NDDI‐E‐Y

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Moreover, to explore the entire epilepsy spectrum and according to their seizure frequency and treatment response, PwE were divided into four groups: A) cases responding to treatment with ≤ 1 seizure per year; B) cases responding to treatment with 2–5 seizure per year; C) cases with drug-resistant epilepsy with ≤ 4 seizures per month; D) cases with drug-resistant epilepsy with 5–10 seizures per month. Finally, eligible PwE underwent several self-report questionnaires regarding therapeutic compliance (Morisky Scale) [ 10 ], mood (Generalized Anxiety Disorder – GAD-7, Patient Health Questionnaire – PHQ9, Neurological Disorder Depression – NDDI-E) [ [11] , [12] , [13] ], stress (Impact of Events Scale-Revised – IES-R, Perceived Stress Scale – PSS-10) [ 14 , 15 ], and sleep (Epworth Sleepinees Scale – ESS, Insomnia Severity Index – ISI) [ 16 , 17 ], during quarantine period. PwE were subjected to standardized telephonic or via telemedicine interview and each questionnaire was self-administered.…”
Section: Methodsmentioning
confidence: 99%
“…Moreover, to explore the entire epilepsy spectrum and according to their seizure frequency and treatment response, PwE were divided into four groups: A) cases responding to treatment with ≤ 1 seizure per year; B) cases responding to treatment with 2–5 seizure per year; C) cases with drug-resistant epilepsy with ≤ 4 seizures per month; D) cases with drug-resistant epilepsy with 5–10 seizures per month. Finally, eligible PwE underwent several self-report questionnaires regarding therapeutic compliance (Morisky Scale) [ 10 ], mood (Generalized Anxiety Disorder – GAD-7, Patient Health Questionnaire – PHQ9, Neurological Disorder Depression – NDDI-E) [ [11] , [12] , [13] ], stress (Impact of Events Scale-Revised – IES-R, Perceived Stress Scale – PSS-10) [ 14 , 15 ], and sleep (Epworth Sleepinees Scale – ESS, Insomnia Severity Index – ISI) [ 16 , 17 ], during quarantine period. PwE were subjected to standardized telephonic or via telemedicine interview and each questionnaire was self-administered.…”
Section: Methodsmentioning
confidence: 99%